101 related articles for article (PubMed ID: 8024947)
1. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
Clementi WA; Garvey TQ; Clifton GD; McCoy RA; Brandt S; Schwartz S
Chirality; 1994; 6(3):169-74. PubMed ID: 8024947
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
Stoschitzky K; Egginger G; Zernig G; Klein W; Lindner W
Chirality; 1993; 5(1):15-9. PubMed ID: 8383518
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study.
Egginger G; Lindner W; Kahr S; Stoschitzky K
Chirality; 1993; 5(7):505-12. PubMed ID: 8240927
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
[TBL] [Abstract][Full Text] [Related]
6. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of racemic and S(-)-atenolol in humans.
McCoy RA; Clifton GD; Clementi WA; Smith MD; Garvey TQ; Wermeling DP; Schwartz SE
J Clin Pharmacol; 1994 Aug; 34(8):816-22. PubMed ID: 7962669
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of two brands of atenolol following a single oral administration.
Irshaid YM; Rawashdeh NM; Awwadi FF; Kato MK
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):457-61. PubMed ID: 8897086
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of two brands of atenolol 100 mg tablets (Tensotin and Tenormin) in healthy human volunteers.
Najib NM; Idkaidek N; Adel A; Mohammed B; Al-Masri S; Admour I; Alam SM; Dham R; Qumaruzaman
Biopharm Drug Dispos; 2005 Jan; 26(1):1-5. PubMed ID: 15578769
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of atenolol enantiomers in 12 Chinese healthy men.
Wang XM; Yu XY; Lin SG
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):367-70. PubMed ID: 10452127
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of atenolol in clinically normal cats.
Quiñones M; Dyer DC; Ware WA; Mehvar R
Am J Vet Res; 1996 Jul; 57(7):1050-3. PubMed ID: 8807020
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.
Macgregor JM; Rush JE; Rozanski EA; Boothe DM; Belmonte AA; Freeman LM
Am J Vet Res; 2008 Jan; 69(1):39-44. PubMed ID: 18167085
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence study of generic atenolol tablets in healthy Thai volunteers.
Rojanasthien N; Manorot M; Kumsorn B
J Med Assoc Thai; 1999 Sep; 82(9):907-14. PubMed ID: 10561948
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
van der Vijgh WJ; Majid PA; de Feyter PJ; Wardeh R; van der Wall EE
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
[TBL] [Abstract][Full Text] [Related]
17. A stereoselective central hypotensive action of atenolol.
Pearson AA; Gaffney TE; Walle T; Privitera PJ
J Pharmacol Exp Ther; 1989 Sep; 250(3):759-63. PubMed ID: 2778713
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits.
Hawkins MG; Taylor IT; Craigmill AL; Tell LA
J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261
[TBL] [Abstract][Full Text] [Related]
19. Effect of rifampicin on the pharmacokinetics of atenolol.
Lilja JJ; Juntti-Patinen L; Neuvonen PJ
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
